Creating smarter ways to fight bacteria
Leading the advancement of technologies and products
that break up biofilms and destroy bacteria.
Alliance Global Partners presents
Medtec Models & Misfires Webinar
Featuring Kane Biotech CEO Marc Edwards
Sept. 15, 2020
Antimicrobial Stewardship and Biofilms: Research Opportunities
This webinar introduces Kane Biotech and two of our anti-biofilm technologies (coactiv+ and DispensinB) to researchers in the Animal Health space in order to establish collaborative research projects leveraging Kane’s expertise and technologies leading to the development and commercialization of products that improve antimicrobial stewardship in animal health.
2019 Business Update Video
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Understanding Biofilms
The study of biofilms has increased significantly in recent years due to the growing awareness of the pervasiveness and impact of biofilms on human and animal health, as well as natural and industrial systems.
Human Health
Biofilms are estimated to be responsible for 80% of all human bacterial infections, costing billions of dollars each year.
Animal Health
The companion pet market in North America has grown to an estimated $62 billion in sales per year, with the oral health care segment growing rapidly at approximately 20%.
Industrial
The rapidly expanding industry for biomedical devices is estimated at $180 billion, yet it continues to suffer from microbial colonization. Microbial infections can develop on all medical devices and hard surfaces.
R+D
For over 10 years Kane Biotech’s R+D division has been developing new technologies and innovations leading to 52 patents and patents pending in biotechnology focusing primarily on biofilm.
Patents and Patents Pending